Is Boundless Bio Stock a good buy in 2024, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NASDAQ: BOLD) stock is to Strong Buy BOLD stock.
Out of 3 analysts, 2 (66.67%) are recommending BOLD as a Strong Buy, 1 (33.33%) are recommending BOLD as a Buy, 0 (0%) are recommending BOLD as a Hold, 0 (0%) are recommending BOLD as a Sell, and 0 (0%) are recommending BOLD as a Strong Sell.
According to 3 Wall Street analysts that have issued a 1 year BOLD price target, the average BOLD price target is $23.00, with the highest BOLD stock price forecast at $25.00 and the lowest BOLD stock price forecast at $20.00.
On average, Wall Street analysts predict that Boundless Bio's share price could reach $23.00 by Apr 22, 2025. The average Boundless Bio stock price prediction forecasts a potential upside of 97.59% from the current BOLD share price of $11.64.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.